ACH Earnings ACCENDRA HEALTH INC/VA/
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q2 2026 | 2026-06-30 | -1.16 | 2026-08-10 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.08 | 2026-05-11 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -0.75 | 2026-02-20 | 10-K |
| FY 2025 | 2025-12-31 | -14.31 | 2026-02-20 | 10-K |
| Q3 2025 | 2025-09-30 | -1.94 | 2025-10-31 | 10-Q |
| Q2 2025 | 2025-06-30 | -11.30 | 2025-08-11 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.32 | 2025-05-08 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -3.86 | 2025-02-28 | 10-K |
| FY 2024 | 2024-12-31 | -4.73 | 2025-02-28 | 10-K |
| Q3 2024 | 2024-09-30 | -0.16 | 2024-11-04 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.42 | 2024-08-02 | 10-Q |
| Q1 2024 | 2024-03-31 | -0.29 | 2024-05-03 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 0.24 | 2024-02-20 | 10-K |
| FY 2023 | 2023-12-31 | -0.53 | 2024-02-20 | 10-K |
| Q3 2023 | 2023-09-30 | -0.08 | 2023-11-03 | 10-Q |
| Q2 2023 | 2023-06-30 | -0.37 | 2023-08-04 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.32 | 2023-05-05 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -0.76 | 2023-02-28 | 10-K |
| FY 2022 | 2022-12-31 | 0.29 | 2023-02-28 | 10-K |
| Q3 2022 | 2022-09-30 | 0.16 | 2022-11-02 | 10-Q |
| Q2 2022 | 2022-06-30 | 0.37 | 2022-08-03 | 10-Q |
| Q1 2022 | 2022-03-31 | 0.52 | 2022-05-04 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 0.51 | 2022-02-23 | 10-K |
| FY 2021 | 2021-12-31 | 2.94 | 2022-02-23 | 10-K |
| Q3 2021 | 2021-09-30 | 0.58 | 2021-11-03 | 10-Q |
| Q2 2021 | 2021-06-30 | 0.87 | 2021-08-03 | 10-Q |
| Q1 2021 | 2021-03-31 | 0.98 | — | — |
| FY 2020 | 2020-12-31 | 0.47 | — | — |
| Q3 2020 | 2020-09-30 | 0.76 | — | — |
| Q2 2020 | 2020-06-30 | -0.91 | — | — |
| FY 2019 | 2019-12-31 | -1.03 | — | — |
| Q2 2017 | 2017-06-30 | 0.33 | 2017-08-02 | 10-Q |
| Q1 2017 | 2017-03-31 | 0.31 | 2017-05-03 | 10-Q |
| Q4 2016 (derived) | 2016-12-31 | 0.44 | 2017-02-17 | 10-K |
| FY 2016 | 2016-12-31 | 1.76 | 2017-02-17 | 10-K |
| Q3 2016 | 2016-09-30 | 0.48 | 2016-11-02 | 10-Q |
| Q2 2016 | 2016-06-30 | 0.45 | 2016-08-03 | 10-Q |
| Q1 2016 | 2016-03-31 | 0.39 | 2016-05-04 | 10-Q |
| Q4 2015 (derived) | 2015-12-31 | 0.51 | 2016-02-25 | 10-K |
| FY 2015 | 2015-12-31 | 1.65 | 2016-02-25 | 10-K |
| Q3 2015 | 2015-09-30 | 0.45 | 2015-10-28 | 10-Q |
| Q2 2015 | 2015-06-30 | 0.39 | 2015-07-28 | 10-Q |
| Q1 2015 | 2015-03-31 | 0.30 | 2015-04-28 | 10-Q |
| Q4 2014 (derived) | 2014-12-31 | 0.22 | 2015-02-23 | 10-K |
| FY 2014 | 2014-12-31 | 1.06 | 2015-02-23 | 10-K |
| Q3 2014 | 2014-09-30 | 0.11 | 2014-10-29 | 10-Q |
| Q2 2014 | 2014-06-30 | 0.32 | 2014-07-30 | 10-Q |
| Q1 2014 | 2014-03-31 | 0.41 | 2014-05-01 | 10-Q |
| Q4 2013 (derived) | 2013-12-31 | 0.45 | 2014-02-25 | 10-K |
| FY 2013 | 2013-12-31 | 1.76 | 2014-02-25 | 10-K |
| Q3 2013 | 2013-09-30 | 0.44 | 2013-11-07 | 10-Q |
| Q2 2013 | 2013-06-30 | 0.46 | 2013-08-02 | 10-Q |
| Q1 2013 | 2013-03-31 | 0.41 | 2013-05-03 | 10-Q |
| Q4 2012 (derived) | 2012-12-31 | 0.39 | 2013-02-22 | 10-K |
| FY 2012 | 2012-12-31 | 1.72 | 2013-02-22 | 10-K |
| Q3 2012 | 2012-09-30 | 0.39 | 2012-11-02 | 10-Q |
| Q2 2012 | 2012-06-30 | 0.48 | 2012-07-27 | 10-Q |
| Q1 2012 | 2012-03-31 | 0.46 | 2012-04-27 | 10-Q |
| Q4 2011 (derived) | 2011-12-31 | 0.37 | 2012-02-24 | 10-K |
| FY 2011 | 2011-12-31 | 1.81 | 2012-02-24 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.